Total Payments
$11,195
2024 Payments
$302.67
Companies
17
Transactions
33
Medicare Patients
13,100
Medicare Billing
$1.1M
Payment Breakdown by Category
Consulting$8,085 (72.2%)
Food & Beverage$1,497 (13.4%)
Travel$1,138 (10.2%)
Other$460.33 (4.1%)
Education$15.27 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $8,085 | 3 | 72.2% |
| Food and Beverage | $1,497 | 23 | 13.4% |
| Travel and Lodging | $1,138 | 4 | 10.2% |
| Honoraria | $350.00 | 1 | 3.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $110.33 | 1 | 1.0% |
| Education | $15.27 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $7,168 | 6 | $0 (2019) |
| GENZYME CORPORATION | $2,170 | 4 | $0 (2019) |
| Biofrontera Inc. | $463.44 | 2 | $0 (2019) |
| ABBVIE INC. | $260.75 | 3 | $0 (2023) |
| Lilly USA, LLC | $192.20 | 5 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $141.83 | 2 | $0 (2019) |
| Arcutis Biotherapeutics, Inc. | $121.00 | 1 | $0 (2024) |
| EPI Health, LLC | $110.33 | 1 | $0 (2022) |
| Regeneron Healthcare Solutions, Inc. | $108.06 | 1 | $0 (2021) |
| Allergan Inc. | $97.33 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $302.67 | 4 | Arcutis Biotherapeutics, Inc. ($121.00) |
| 2023 | $265.16 | 4 | ABBVIE INC. ($204.29) |
| 2022 | $260.91 | 4 | EPI Health, LLC ($110.33) |
| 2021 | $108.06 | 1 | Regeneron Healthcare Solutions, Inc. ($108.06) |
| 2020 | $41.97 | 3 | Lilly USA, LLC ($41.97) |
| 2019 | $9,947 | 14 | Janssen Biotech, Inc. ($7,168) |
| 2018 | $94.33 | 1 | SANOFI-AVENTIS U.S. LLC ($94.33) |
| 2017 | $175.86 | 2 | Novartis Pharmaceuticals Corporation ($97.19) |
All Payment Transactions
33 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/26/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $121.00 | General |
| Category: Dermatology | ||||||
| 10/26/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $72.05 | General |
| Category: Immunology | ||||||
| 10/25/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $49.89 | General |
| Category: DERMATOLOGY | ||||||
| 10/24/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $59.73 | General |
| Category: Dermatology | ||||||
| 10/03/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $97.64 | General |
| Category: IMMUNOLOGY | ||||||
| 03/16/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $45.60 | General |
| Category: Immunology | ||||||
| 03/02/2023 | PFIZER INC. | CIBINQO (Drug) | Education | In-kind items and services | $15.27 | General |
| Category: Inflammation & Immunology | ||||||
| 01/19/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $106.65 | General |
| Category: IMMUNOLOGY | ||||||
| 11/10/2022 | Lilly USA, LLC | — | Food and Beverage | Cash or cash equivalent | $71.56 | General |
| 11/09/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: IMMUNOLOGY | ||||||
| 03/28/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $56.46 | General |
| Category: IMMUNOLOGY | ||||||
| 03/27/2022 | EPI Health, LLC | WYNZORA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $110.33 | General |
| Category: DERMATOLOGY | ||||||
| 12/11/2021 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $108.06 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 01/13/2020 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $32.28 | General |
| 01/13/2020 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $6.78 | General |
| 01/13/2020 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $2.91 | General |
| 09/25/2019 | Janssen Biotech, Inc. | Tremfya (Drug) | Consulting Fee | Cash or cash equivalent | $825.00 | General |
| Category: Immunology | ||||||
| 07/15/2019 | GENZYME CORPORATION | DUPIXENT (Drug) | Consulting Fee | Cash or cash equivalent | $1,760.00 | General |
| Category: IMMUNOLOGY | ||||||
| 07/15/2019 | GENZYME CORPORATION | DUPIXENT (Drug) | Travel and Lodging | Cash or cash equivalent | $286.23 | General |
| Category: IMMUNOLOGY | ||||||
| 07/15/2019 | GENZYME CORPORATION | DUPIXENT (Drug) | Travel and Lodging | Cash or cash equivalent | $81.78 | General |
| Category: IMMUNOLOGY | ||||||
| 07/15/2019 | SANOFI-AVENTIS U.S. LLC | DUPIXENT (Drug) | Food and Beverage | In-kind items and services | $47.50 | General |
| Category: IMMUNOLOGY | ||||||
| 07/15/2019 | GENZYME CORPORATION | DUPIXENT (Drug) | Travel and Lodging | Cash or cash equivalent | $42.00 | General |
| Category: IMMUNOLOGY | ||||||
| 06/12/2019 | Janssen Biotech, Inc. | Tremfya (Drug) | Consulting Fee | Cash or cash equivalent | $5,500.00 | General |
| Category: Immunology | ||||||
| 06/12/2019 | Janssen Biotech, Inc. | Tremfya (Drug) | Travel and Lodging | In-kind items and services | $728.26 | General |
| Category: Immunology | ||||||
| 06/12/2019 | Janssen Biotech, Inc. | Tremfya (Drug) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 2,731 | 4,741 | $1.0M | $184,426 |
| 2022 | 24 | 3,158 | 5,459 | $1.6M | $249,313 |
| 2021 | 23 | 3,470 | 6,500 | $1.7M | $314,522 |
| 2020 | 29 | 3,741 | 6,644 | $1.8M | $309,091 |
Total Patients
13,100
Total Services
23,344
Medicare Billing
$1.1M
Procedure Codes
91
All Medicare Procedures & Services
91 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 577 | 799 | $233,545 | $63,757 | 27.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 544 | 666 | $128,762 | $36,942 | 28.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 541 | 688 | $201,775 | $25,933 | 12.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 227 | 270 | $117,724 | $15,956 | 13.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 165 | 187 | $59,336 | $8,328 | 14.0% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 55 | 72 | $59,877 | $7,302 | 12.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 392 | 1,784 | $105,433 | $5,607 | 5.3% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 39 | 55 | $29,439 | $4,555 | 15.5% |
| 17282 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 28 | 36 | $19,236 | $3,945 | 20.5% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 21 | 21 | $30,828 | $3,598 | 11.7% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 17 | 18 | $13,707 | $1,861 | 13.6% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 21 | 27 | $9,780 | $1,714 | 17.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 50 | 50 | $6,175 | $1,694 | 27.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 37 | 51 | $10,134 | $1,674 | 16.5% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 17 | 17 | $8,659 | $1,560 | 18.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 608 | 803 | $317,377 | $71,966 | 22.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 630 | 781 | $200,716 | $50,480 | 25.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 611 | 808 | $304,748 | $32,289 | 10.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 252 | 293 | $164,238 | $22,528 | 13.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 173 | 194 | $93,993 | $13,148 | 14.0% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 75 | 94 | $93,020 | $11,680 | 12.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 464 | 2,061 | $157,302 | $10,614 | 6.7% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 35 | 38 | $58,265 | $8,700 | 14.9% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 30 | 38 | $32,977 | $4,817 | 14.6% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2022 | 11 | 11 | $14,842 | $3,204 | 21.6% |
About Dr. Andrew Kim, MD
Dr. Andrew Kim, MD is a Dermatology healthcare provider based in Concord, New Hampshire. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/09/2013. The National Provider Identifier (NPI) number assigned to this provider is 1235572207.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andrew Kim, MD has received a total of $11,195 in payments from pharmaceutical and medical device companies, with $302.67 received in 2024. These payments were reported across 33 transactions from 17 companies. The most common payment nature is "Consulting Fee" ($8,085).
As a Medicare-enrolled provider, Kim has provided services to 13,100 Medicare beneficiaries, totaling 23,344 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 91 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Concord, NH
- Active Since 04/09/2013
- Last Updated 12/12/2025
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1235572207
Products in Payments
- Tremfya (Drug) $7,168
- DUPIXENT (Drug) $2,218
- Ameluz (Drug) $463.44
- SKYRIZI (Biological) $154.10
- Zoryve (Drug) $121.00
- WYNZORA (Drug) $110.33
- DUPIXENT (Biological) $108.06
- RINVOQ (Biological) $106.65
- COSENTYX (Biological) $97.19
- DISEASE STATE (Drug) $94.33
- Bimzelx (Biological) $72.05
- OPZELURA (Drug) $59.73
- ADBRY (Biological) $49.89
- Sotyktu (Drug) $45.60
- NUCALA (Biological) $22.56
- CIBINQO (Drug) $15.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Concord
William Hoover, Md, MD
Dermatology — Payments: $651,837
Dermatology $651,837
Dr. Heather Holahan, Md, MD
Dermatology — Payments: $15,616
Dermatology $15,616
Dr. Dhwani Mehta, Md, MD
Dermatology — Payments: $11,646
Dermatology $11,646
Dr. Lacey Walls, D.o, D.O
Dermatology — Payments: $11,558
Dermatology $11,558
Nava Greenfield, Md, MD
Dermatology — Payments: $10,175
Dermatology $10,175
Dr. Alexis Perkins, Md, MD
Dermatology — Payments: $7,068
Dermatology $7,068